Cardinal Health (NYSE:CAH) has received a short term rating of sell from experts at Zacks with a rank of 4. The stock has been rated an average of 2 by 13 Brokerage Firm. 6 Wall Street Firms have rated the stock as a strong buys. 1 stock experts have also suggested a buy rating. 6 Brokerage Firms have advised hold.
Other Equity analysts have also commented on the company shares. Equity analysts at the Brokerage firm Bank of America reinstates its rating on Cardinal Health (NYSE:CAH). The rating major has initiated the coverage with neutral rating on the shares. The rating by the firm was issued on June 7, 2016.
Cardinal Health (NYSE:CAH): The stock price is expected to reach $ 93.18 in the short term. The number of analysts agreeing with this consensus is 11. The higher estimate for the short term price target is at $111 while the lower estimate is at $83. The standard deviation of the price stands at $8.65.
Cardinal Health (NYSE:CAH) rose 0.54% or 0.41 points on Tuesday and made its way into the gainers of the day. After trading began at $76.82 the stock was seen hitting $77.06 as a peak level and $76.31 as the lowest level. The stock ended up at $76.89. The daily volume was measured at 1,855,021 shares. The 52-week high of the share price is $91.225 and the 52-week low is $74.73. The company has a market cap of $25,052 million.
Cardinal Health, Inc. has lost 1.33% in the last five trading days and dropped 0.67% in the last 4 weeks. Cardinal Health, Inc. has dropped 4.81% during the last 3-month period . Year-to-Date the stock performance stands at -13.46%.
Cardinal Health, Inc. is a healthcare services and products company. The Company operates in two segments: Pharmaceutical and Medical. The Company also provides medical products to patients in the home. In the United States, the Companys Pharmaceutical segment distributes branded and generic pharmaceutical, over-the-counter healthcare and consumer products through its Pharmaceutical Distribution division to retailers, hospitals and other healthcare providers. In China, the Pharmaceutical segment distributes branded, generic and specialty pharmaceutical, over-the-counter healthcare and consumer products, provides logistics, marketing and other services and operates direct-to-patient specialty pharmacies through Cardinal Health China. The Medical segment distributes a range of medical, surgical and laboratory products and provides services to hospitals, ambulatory surgery centers, clinical laboratories and other healthcare providers.